ReviewCurrent cancer drug targets2026
Targeting Glutamine Metabolic Reprogramming in Pancreatic Cancer: Current Insights and Future Directions.
Yanhui Ma et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it